Houston-based Bellicum Pharmaceuticals Inc. (Nasdaq: BLCM), a clinical-stage biopharmaceutical company focused on cellular immunotherapies, is selling a local facility to the University of Texas M.D. Anderson Cancer Center. M.D. Anderson will pay $15 million for the 60,000-square-foot facility, including manufacturing, office and laboratory space, according to a press release. Approximately 35 employees at the facility will transfer to M.D.

  • Houston Health Care News
    Houston-area biotech co. to hire, double office space after $73.6M IPO © 2020 American City Business Journals. All rights reserved. Use of and/or registration on any ...
    02/20/2020 - 4:22 am | View Link
  • Local physician dedicates his life to breast cancer prevention
    Powel Brown has dedicated the past 30 years to researching breast cancer, a disease that has directly affected his personal life. Early in his training, Dr. Brown, a physician at MD Anderson ...
    02/10/2020 - 12:20 am | View Link
  • Top Houston news: Activist joins fight for 'cancer cluster' answers; deputy injured in crash; more
    Residents of a state-identified “cancer cluster” in northeast Houston continued their call for action Tuesday as a well-known activist joined their cause. The crash was reported about 5:50 a.m.
    01/22/2020 - 3:58 am | View Link
  • More


Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News